A randomized clinical trial to evaluate two doses of an intra-articular injection of LMWF-5A in adults with pain due to osteoarthritis of the knee.

<h4>Objective</h4>The Low Molecular Weight Fraction of 5% human serum Albumin (LMWF-5A) is being investigated as a treatment for knee pain from osteoarthritis.<h4>Methods</h4>This was a multicenter randomized, vehicle-controlled, double-blind, parallel study designed to evalu...

Full description

Saved in:
Bibliographic Details
Main Authors: David Bar-Or, Kristin M Salottolo, Holli Loose, Matthew J Phillips, Brian McGrath, Nathan Wei, James L Borders, John E Ervin, Alan Kivitz, Mark Hermann, Tammi Shlotzhauer, Melvin Churchill, Donald Slappey, Vaughan Clift
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0087910&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849468613339119616
author David Bar-Or
Kristin M Salottolo
Holli Loose
Matthew J Phillips
Brian McGrath
Nathan Wei
James L Borders
John E Ervin
Alan Kivitz
Mark Hermann
Tammi Shlotzhauer
Melvin Churchill
Donald Slappey
Vaughan Clift
author_facet David Bar-Or
Kristin M Salottolo
Holli Loose
Matthew J Phillips
Brian McGrath
Nathan Wei
James L Borders
John E Ervin
Alan Kivitz
Mark Hermann
Tammi Shlotzhauer
Melvin Churchill
Donald Slappey
Vaughan Clift
author_sort David Bar-Or
collection DOAJ
description <h4>Objective</h4>The Low Molecular Weight Fraction of 5% human serum Albumin (LMWF-5A) is being investigated as a treatment for knee pain from osteoarthritis.<h4>Methods</h4>This was a multicenter randomized, vehicle-controlled, double-blind, parallel study designed to evaluate the safety and efficacy of two doses of an intra-articular injection of LMWF-5A. Patients with symptomatic knee osteoarthritis were randomized 1∶1∶1∶1 to receive a single 4 mL or 10 mL intra-articular knee injection of either LMWF-5A or vehicle control (saline). The primary efficacy endpoint was the difference between treatment groups in the Western Ontario and McMaster Universities (WOMAC) pain change from baseline over 12 weeks. Safety was examined as the incidence and severity of adverse events (AEs).<h4>Results</h4>A total of 329 patients were randomized and received treatment. LMWF-5A resulted in a significant decrease in pain at 12 weeks compared to vehicle control (-0.93 vs -0.72; estimated difference from control: -0.25, p = 0.004); an injection volume effect was not observed (p = 0.64). The effect of LMWF-5A on pain was even more pronounced in patients with severe knee OA (Kellgren Lawrence Grade IV): the estimated difference from control was -0.42 (p = 0.02). Adverse events were generally mild and were similar in patients who received vehicle control (47%) and LMWF-5A (41%).<h4>Conclusions</h4>This clinical trial demonstrated that LMWF-5A is safe and effective at providing relief for the pain of moderate to severe OA of the knee over 12 weeks when administered by intra-articular injection into the knee.<h4>Trial registration</h4>ClinicalTrials.gov NCT01839331.
format Article
id doaj-art-e1bfdd55b30146dd8a4e9e777b17fbcc
institution Kabale University
issn 1932-6203
language English
publishDate 2014-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-e1bfdd55b30146dd8a4e9e777b17fbcc2025-08-20T03:25:47ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0192e8791010.1371/journal.pone.0087910A randomized clinical trial to evaluate two doses of an intra-articular injection of LMWF-5A in adults with pain due to osteoarthritis of the knee.David Bar-OrKristin M SalottoloHolli LooseMatthew J PhillipsBrian McGrathNathan WeiJames L BordersJohn E ErvinAlan KivitzMark HermannTammi ShlotzhauerMelvin ChurchillDonald SlappeyVaughan Clift<h4>Objective</h4>The Low Molecular Weight Fraction of 5% human serum Albumin (LMWF-5A) is being investigated as a treatment for knee pain from osteoarthritis.<h4>Methods</h4>This was a multicenter randomized, vehicle-controlled, double-blind, parallel study designed to evaluate the safety and efficacy of two doses of an intra-articular injection of LMWF-5A. Patients with symptomatic knee osteoarthritis were randomized 1∶1∶1∶1 to receive a single 4 mL or 10 mL intra-articular knee injection of either LMWF-5A or vehicle control (saline). The primary efficacy endpoint was the difference between treatment groups in the Western Ontario and McMaster Universities (WOMAC) pain change from baseline over 12 weeks. Safety was examined as the incidence and severity of adverse events (AEs).<h4>Results</h4>A total of 329 patients were randomized and received treatment. LMWF-5A resulted in a significant decrease in pain at 12 weeks compared to vehicle control (-0.93 vs -0.72; estimated difference from control: -0.25, p = 0.004); an injection volume effect was not observed (p = 0.64). The effect of LMWF-5A on pain was even more pronounced in patients with severe knee OA (Kellgren Lawrence Grade IV): the estimated difference from control was -0.42 (p = 0.02). Adverse events were generally mild and were similar in patients who received vehicle control (47%) and LMWF-5A (41%).<h4>Conclusions</h4>This clinical trial demonstrated that LMWF-5A is safe and effective at providing relief for the pain of moderate to severe OA of the knee over 12 weeks when administered by intra-articular injection into the knee.<h4>Trial registration</h4>ClinicalTrials.gov NCT01839331.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0087910&type=printable
spellingShingle David Bar-Or
Kristin M Salottolo
Holli Loose
Matthew J Phillips
Brian McGrath
Nathan Wei
James L Borders
John E Ervin
Alan Kivitz
Mark Hermann
Tammi Shlotzhauer
Melvin Churchill
Donald Slappey
Vaughan Clift
A randomized clinical trial to evaluate two doses of an intra-articular injection of LMWF-5A in adults with pain due to osteoarthritis of the knee.
PLoS ONE
title A randomized clinical trial to evaluate two doses of an intra-articular injection of LMWF-5A in adults with pain due to osteoarthritis of the knee.
title_full A randomized clinical trial to evaluate two doses of an intra-articular injection of LMWF-5A in adults with pain due to osteoarthritis of the knee.
title_fullStr A randomized clinical trial to evaluate two doses of an intra-articular injection of LMWF-5A in adults with pain due to osteoarthritis of the knee.
title_full_unstemmed A randomized clinical trial to evaluate two doses of an intra-articular injection of LMWF-5A in adults with pain due to osteoarthritis of the knee.
title_short A randomized clinical trial to evaluate two doses of an intra-articular injection of LMWF-5A in adults with pain due to osteoarthritis of the knee.
title_sort randomized clinical trial to evaluate two doses of an intra articular injection of lmwf 5a in adults with pain due to osteoarthritis of the knee
url https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0087910&type=printable
work_keys_str_mv AT davidbaror arandomizedclinicaltrialtoevaluatetwodosesofanintraarticularinjectionoflmwf5ainadultswithpainduetoosteoarthritisoftheknee
AT kristinmsalottolo arandomizedclinicaltrialtoevaluatetwodosesofanintraarticularinjectionoflmwf5ainadultswithpainduetoosteoarthritisoftheknee
AT holliloose arandomizedclinicaltrialtoevaluatetwodosesofanintraarticularinjectionoflmwf5ainadultswithpainduetoosteoarthritisoftheknee
AT matthewjphillips arandomizedclinicaltrialtoevaluatetwodosesofanintraarticularinjectionoflmwf5ainadultswithpainduetoosteoarthritisoftheknee
AT brianmcgrath arandomizedclinicaltrialtoevaluatetwodosesofanintraarticularinjectionoflmwf5ainadultswithpainduetoosteoarthritisoftheknee
AT nathanwei arandomizedclinicaltrialtoevaluatetwodosesofanintraarticularinjectionoflmwf5ainadultswithpainduetoosteoarthritisoftheknee
AT jameslborders arandomizedclinicaltrialtoevaluatetwodosesofanintraarticularinjectionoflmwf5ainadultswithpainduetoosteoarthritisoftheknee
AT johneervin arandomizedclinicaltrialtoevaluatetwodosesofanintraarticularinjectionoflmwf5ainadultswithpainduetoosteoarthritisoftheknee
AT alankivitz arandomizedclinicaltrialtoevaluatetwodosesofanintraarticularinjectionoflmwf5ainadultswithpainduetoosteoarthritisoftheknee
AT markhermann arandomizedclinicaltrialtoevaluatetwodosesofanintraarticularinjectionoflmwf5ainadultswithpainduetoosteoarthritisoftheknee
AT tammishlotzhauer arandomizedclinicaltrialtoevaluatetwodosesofanintraarticularinjectionoflmwf5ainadultswithpainduetoosteoarthritisoftheknee
AT melvinchurchill arandomizedclinicaltrialtoevaluatetwodosesofanintraarticularinjectionoflmwf5ainadultswithpainduetoosteoarthritisoftheknee
AT donaldslappey arandomizedclinicaltrialtoevaluatetwodosesofanintraarticularinjectionoflmwf5ainadultswithpainduetoosteoarthritisoftheknee
AT vaughanclift arandomizedclinicaltrialtoevaluatetwodosesofanintraarticularinjectionoflmwf5ainadultswithpainduetoosteoarthritisoftheknee
AT davidbaror randomizedclinicaltrialtoevaluatetwodosesofanintraarticularinjectionoflmwf5ainadultswithpainduetoosteoarthritisoftheknee
AT kristinmsalottolo randomizedclinicaltrialtoevaluatetwodosesofanintraarticularinjectionoflmwf5ainadultswithpainduetoosteoarthritisoftheknee
AT holliloose randomizedclinicaltrialtoevaluatetwodosesofanintraarticularinjectionoflmwf5ainadultswithpainduetoosteoarthritisoftheknee
AT matthewjphillips randomizedclinicaltrialtoevaluatetwodosesofanintraarticularinjectionoflmwf5ainadultswithpainduetoosteoarthritisoftheknee
AT brianmcgrath randomizedclinicaltrialtoevaluatetwodosesofanintraarticularinjectionoflmwf5ainadultswithpainduetoosteoarthritisoftheknee
AT nathanwei randomizedclinicaltrialtoevaluatetwodosesofanintraarticularinjectionoflmwf5ainadultswithpainduetoosteoarthritisoftheknee
AT jameslborders randomizedclinicaltrialtoevaluatetwodosesofanintraarticularinjectionoflmwf5ainadultswithpainduetoosteoarthritisoftheknee
AT johneervin randomizedclinicaltrialtoevaluatetwodosesofanintraarticularinjectionoflmwf5ainadultswithpainduetoosteoarthritisoftheknee
AT alankivitz randomizedclinicaltrialtoevaluatetwodosesofanintraarticularinjectionoflmwf5ainadultswithpainduetoosteoarthritisoftheknee
AT markhermann randomizedclinicaltrialtoevaluatetwodosesofanintraarticularinjectionoflmwf5ainadultswithpainduetoosteoarthritisoftheknee
AT tammishlotzhauer randomizedclinicaltrialtoevaluatetwodosesofanintraarticularinjectionoflmwf5ainadultswithpainduetoosteoarthritisoftheknee
AT melvinchurchill randomizedclinicaltrialtoevaluatetwodosesofanintraarticularinjectionoflmwf5ainadultswithpainduetoosteoarthritisoftheknee
AT donaldslappey randomizedclinicaltrialtoevaluatetwodosesofanintraarticularinjectionoflmwf5ainadultswithpainduetoosteoarthritisoftheknee
AT vaughanclift randomizedclinicaltrialtoevaluatetwodosesofanintraarticularinjectionoflmwf5ainadultswithpainduetoosteoarthritisoftheknee